Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chiron Sports Group is a London-based sports investment and advisory firm founded in 2023. The company specializes in identifying high-growth opportunities within the global sports sector by leveraging brand development, community engagement strategies, and innovative commercial models. Backed by prominent family offices such as Christian Angermayer’s Apeiron Investment Group and Robin Lauber’s Infinitas Capital, it has quickly grown its team and portfolio since inception. The group focuses on private equity investments across U.S. sports franchises, women’s sports teams/leagues, emerging markets assets (such as electric speedboat racing), and underutilized clubs with potential for global brand expansion.
The leadership team includes co-founders Sam Helmy (background in real estate private equity) and Leo Rifkind (background in M&A law), both of whom have direct experience operating football clubs across Europe. Their approach combines operational expertise with financial acumen to drive value creation.
There are no clinical programs or drug development activities associated with this entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chiron Sports Group.